Exploration of Gender Differences in Liver Aging
1 other identifier
observational
18
1 country
1
Brief Summary
The liver is an important metabolic organ in the body. It participates in central metabolic activities to maintain systemic homeostasis. It is also one of the most vulnerable organs in the process of individual aging. During aging, the volume, blood flow, metabolic capacity and regenerative capacity of the liver decrease. Liver function changes with age can lead to age-related systemic susceptibility diseases. Therefore, understanding the changes of metabolism and immune function in the process of liver aging and studying the regulation mechanism of liver aging will provide an important reference for understanding the causes of increased susceptibility to liver-related diseases in the elderly population.On the other hand, gender factors also affect organ function, leading to differences in human aging and disease outcomes.At present, the omics research on liver aging is mainly based on tissue-level transcription, protein or metabolomics, and most of the conclusions are focused on hepatocytes. However, for other cell types and microenvironment interactions, people know little about the aging changes at the cellular levelBased on the current research status, this study aims to explore the gender differences in the process of liver aging, using emerging technologies such as the combination of single-cell multi-omics and spatial localization, to reveal the factors driving liver aging from a gender perspective, and to promote the development of accurate interventions for aging and aging-related diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
September 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 20, 2027
October 8, 2024
September 1, 2024
3 years
September 8, 2024
October 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Molecular and cellular characteristics during liver aging
Draw the map information of liver aging single cell precision, and clarify whether the effect of aging on liver cell types has gender differences.
2027.08
Eligibility Criteria
In this study, the normal liver sampling criteria are as follows : 1.Preoperative blood biochemical liver function indicators are in the normal reference range. 2.Liver imaging is normal. The liver is normal in size, regular in shape, smooth in capsule, uniform in parenchymal echo, and intrahepatic vascular network. For patients undergoing laparoscopic cholecystectomy, the liver tissue of the IV segment of the liver ( about 1mm3 ) was separated from the gallbladder wall specimen.
You may qualify if:
- Liver function indicators are in the normal reference range.
- Liver imaging examination showed normal.
You may not qualify if:
- Patients with previous liver-related diseases.
- Subjects with important organ dysfunction / failure or other serious diseases ( myocardial infarction, malignant tumor, severe neurological or psychiatric history, severe infection, coagulation dysfunction, etc. )
- Moderate malnutrition ( BMI \< 17kg / m2 ) and severe anemia ( Hb \< 60g / L ).
- Subjects and their families who disagreed with the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, No.88 Jiefang Road, China
Biospecimen
Liver tissue of segment IV ( about 1mm³ )
Study Officials
- STUDY DIRECTOR
daren Liu, MD, PhD
Zhejiang University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2024
First Posted
September 19, 2024
Study Start
September 27, 2024
Primary Completion (Estimated)
September 15, 2027
Study Completion (Estimated)
September 20, 2027
Last Updated
October 8, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share